- Elevation Oncology Announces Planned Combination Strategy for EO-3021 in Patients with Gastric or Gastroesophageal Junction Cancer
- Elevation Oncology to Present at the Citizens JMP Life Sciences Conference
- Elevation Oncology Reports First Quarter 2024 Financial Results and Highlights Recent Business Achievements
Key statistics
On Friday, Elevation Oncology Inc (ELEV:NSQ) closed at 2.64, 627.27% above the 52 week low of 0.363 set on Nov 13, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.65 |
---|---|
High | 2.78 |
Low | 2.62 |
Bid | 2.46 |
Offer | 2.69 |
Previous close | 2.64 |
Average volume | 1.20m |
---|---|
Shares outstanding | 54.64m |
Free float | 51.81m |
P/E (TTM) | -- |
Market cap | 157.90m USD |
EPS (TTM) | -1.03 USD |
Data delayed at least 15 minutes, as of Jul 19 2024 21:00 BST.
More ▼